The use of leukocytes’ secretome to individually target biological therapy in autoimmune arthritis: a case report

BACKGROUND: Biological agents have allowed remarkable improvement in controlling autoimmune arthropathies, although none of the numerous biologics readily available represent a universal treatment standard. Moreover, classical and genetic predictors are currently unsatisfactory to predict individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Poubelle, Patrice E., Pagé, Nathalie, Longchamps, Marie-Pier, Sampaio Moura, Natalia, Beck, David B., Aksentijevich, Ivona, Tessier, Philippe A., Pelletier, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548783/
https://www.ncbi.nlm.nih.gov/pubmed/31165299
http://dx.doi.org/10.1186/s40169-019-0236-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548783/
https://www.ncbi.nlm.nih.gov/pubmed/31165299
http://dx.doi.org/10.1186/s40169-019-0236-7

Ejemplares similares